InicioCarterasWatchlistComunidadDescubreScreener
NOT FOR DISTRIBUTION

Victrex plc

Informe acción LSE:VCT

Capitalización de mercado: UK£830.7m

  • Resumen empresa
    • Valoración
    • Crecimiento Futuro
    • Rendimiento pasado
    • Salud Financiera
    • Dividendos
  • Dirección
  • Propiedad
  • Información adicional
  • Comunidad de acciones

Victrex Crecimiento futuro

Future controles de criterios 4/6

Se prevé un crecimiento anual de los beneficios y los ingresos de Victrex de 98.1% y 4% por año respectivamente. Se prevé que el BPA crezca en un 78.4% al año. Se espera que la rentabilidad financiera sea de 14.7% en 3 años.

Información clave

98.1%

Tasa de crecimiento de los beneficios

78.37%

Tasa de crecimiento del BPA

Crecimiento de los beneficios de Chemicals34.5%
Tasa de crecimiento de los ingresos4.0%
Rentabilidad financiera futura14.73%
Cobertura de analistas

Good

Última actualización11 Sep 2026

Actualizaciones recientes sobre el crecimiento futuro

Recent updates

User avatar
Actualización de narrativa • Sep 09

VCT: Profit Improvement Plan And Leadership Transition Will Shape Future Re Rating

Analysts have raised their price target on Victrex from £8.49 to £9.70, citing updated assumptions on discount rates, revenue growth, profit margins and future P/E expectations. What’s in the News for Victrex Victrex appointed Chris Gilbert as Interim Chief Financial Officer, effective 1 September 2026, with experience at Elementis plc and Deloitte LLP, according to company disclosures.
User avatar
Actualización de narrativa • Jun 22

VCT: Margin Progress And Lower P/E Framework Will Support Future Re Rating

Analysts have nudged their Victrex price target slightly lower to £8.49 from £8.51, citing updated assumptions around revenue growth, profit margins and future P/E expectations that leave the overall valuation broadly unchanged. What's in the News No recent Victrex specific news items or key developments were available from the provided sources.
User avatar
Actualización de narrativa • Jun 05

VCT: Updated Discount Rate And P E Assumptions Will Shape Future Rerating

Analysts have trimmed their price target on Victrex by £1.00, citing updated assumptions for discount rates, revenue growth, profit margins and future P/E multiples that slightly reshape the company’s risk and return profile. What's in the News No recent company specific news for Victrex has been provided in the available sources.
User avatar
Actualización de narrativa • May 21

VCT: Margin Execution And Lower P/E Framework Will Support Future Re Rating

Analysts have trimmed their implied price target on Victrex by about £0.39, citing updated assumptions around profit margins, revenue growth and a lower future P/E multiple following recent Street research. Analyst Commentary Street research around Victrex has shifted to a more cautious stance on valuation, with the latest move being a £1.00 cut to the implied price target from JPMorgan.
User avatar
Actualización de narrativa • May 01

VCT: Cautious P E And Discount Rate Assumptions Will Shape Future Rerating

Analysts have trimmed their price target on Victrex by £1.00, citing updated assumptions around the discount rate, revenue growth, profit margins and future P/E. These changes modestly adjust their outlook on the shares.
User avatar
Actualización de narrativa • Apr 17

VCT: Cautious Growth And Margin Assumptions Will Shape Future P E Rerating

Analysts have lowered their price target on Victrex by £1.00, citing updates to assumptions around discount rate, revenue growth, profit margin and future P/E that collectively suggest a more balanced risk and return profile. Analyst Commentary Recent commentary around Victrex has tilted more cautious, with the latest £1.00 cut in the price target, including the 100 GBp adjustment referenced in recent research, highlighting increased focus on valuation and execution risks.
User avatar
Actualización de narrativa • Apr 03

VCT: Refined Cash Flow Assumptions Will Support Future Re Rating Potential

Analysts have trimmed their price target on Victrex by £1.00, citing updated assumptions around discount rates, revenue growth, and profit margins as key drivers of the revision. Analyst Commentary JPMorgan has reduced its price target on Victrex by £1.00, reflecting refreshed assumptions around discount rates, revenue growth, and margins.
User avatar
Actualización de narrativa • Mar 19

VCT: Future Upside Will Be Anchored By Resilient Earnings Framework

Analysts have trimmed their price target on Victrex by £1.00, reflecting slightly lower fair value estimates and modestly softer assumptions for revenue growth and profit margins, while still using a similar discount rate and future P/E multiple. Analyst Commentary Bullish Takeaways Bullish analysts view the £1.00 reduction in the price target as a fine tuning of fair value rather than a shift in the long term thesis, with the core assumptions on discount rate and future P/E multiple kept broadly intact.
User avatar
Actualización de narrativa • Mar 05

VCT: Future Upside Will Be Supported By Resilient Earnings Assumptions

Analysts have trimmed their price target for Victrex to £7.32 from £7.48. This reflects updated views on its long term fair value, discount rate, revenue growth, profit margin and future P/E assumptions.
User avatar
Actualización de narrativa • Feb 19

VCT: Higher Growth Assumptions Will Set Up Future Re Rating Opportunity

Analysts have trimmed their price target for Victrex to £8.90. This reflects slightly higher assumed discount and revenue growth rates, together with a small adjustment to forecast profit margins and future P/E expectations.
User avatar
Actualización de narrativa • Feb 05

VCT: Sector Downgrade And Lower Future P E Multiple Will Cap Rerating Potential

Analysts have trimmed their price expectations for Victrex, reflecting slightly higher discount rate assumptions, modestly different revenue growth and profit margin forecasts, and a lower future P/E multiple in light of more cautious sector views on European chemicals. Analyst Commentary Bearish analysts have taken a more cautious stance on Victrex, in line with a broader push to reduce risk within European chemicals.
Artículo de análisis • Jan 27

Does Victrex (LON:VCT) Have A Healthy Balance Sheet?

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
User avatar
Actualización de narrativa • Jan 22

VCT: Sector Downgrade Will Set Up Opportunity For Future Re‑Rating

Analysts have reduced their fair value estimate for Victrex from £11.00 to £8.90, citing more cautious views on diversified chemicals and a preference for other parts of the European chemicals sector as key drivers of the updated price target assumptions. Analyst Commentary Recent research highlights a more cautious stance on diversified chemicals, with Victrex now grouped alongside peers where sentiment is restrained compared with preferred sub sectors such as industrial gases, ingredients, and distributors.
Artículo de análisis • Jan 09

Victrex (LON:VCT) Has Affirmed Its Dividend Of £0.4614

The board of Victrex plc ( LON:VCT ) has announced that it will pay a dividend of £0.4614 per share on the 27th of...
User avatar
Actualización de narrativa • Jan 08

VCT: Future Upside Will Be Driven By Resilient Earnings Power

Narrative Update Analysts have trimmed their fair value estimate for Victrex to reflect a lower price target of £9.40 from £11.00, citing a more cautious stance on European chemicals while still noting relatively steady assumptions for growth, margins and future P/E. Analyst Commentary Recent research updates on Victrex point to a more mixed stance, with some analysts maintaining a constructive view on the shares and others taking a more cautious approach to the broader European chemicals space.
User avatar
Actualización de narrativa • Dec 24

VCT: Sector Caution And Rating Downgrade Will Pressure Share Rerating Potential

Analysts have trimmed their fair value estimate for Victrex from £6.75 to £5.75, reflecting a slightly higher discount rate, softer medium term revenue and margin expectations, and recent price target cuts from the Street. Analyst Commentary Recent Street updates underline a more cautious stance on Victrex, with bearish analysts revising ratings and price targets lower in response to sector headwinds and company specific execution risks.
Artículo de análisis • Dec 24

Victrex (LON:VCT) Is Due To Pay A Dividend Of £0.4614

The board of Victrex plc ( LON:VCT ) has announced that it will pay a dividend on the 27th of February, with investors...
User avatar
Actualización de narrativa • Dec 10

VCT: Future Upside Will Be Driven By Medical Volume Rebound

Analysts have trimmed their price targets on Victrex, cutting the implied fair value by roughly 2 percent to reflect softer margin expectations and sector headwinds, even as they acknowledge improving revenue growth prospects along with a higher future P/E multiple. Analyst Commentary Street commentary on Victrex has become more balanced, with recent notes highlighting both improving medium term growth prospects and persistent execution risks that could cap near term upside.
Artículo de análisis • Dec 10

We Like The Quality Of Victrex's (LON:VCT) Earnings

Shareholders appeared to be happy with Victrex plc's ( LON:VCT ) solid earnings report last week. This reaction by the...
Artículo de análisis • Dec 05

Victrex (LON:VCT) Has Announced A Dividend Of £0.4614

Victrex plc ( LON:VCT ) will pay a dividend of £0.4614 on the 27th of February. Based on this payment, the dividend...
User avatar
Actualización de narrativa • Nov 26

VCT: Future Recovery Will Be Driven By Medical Volume Rebound

Victrex's analyst price targets have been revised downward, with a notable reduction from previous estimates such as 1,100 GBp to 940 GBp. Analysts cite ongoing caution towards the European chemicals sector and softer expectations for the company's recovery. Analyst Commentary Recent analyst assessments reflect a shift in sentiment towards Victrex's near-term performance and sector positioning.
User avatar
Actualización de narrativa • Nov 11

VCT: Future Leadership Transition Will Guide Recovery As Margins Improve

Analysts have reduced their price targets for Victrex, with consensus moving from approximately £8.77 to £8.11 per share. This reflects concerns about weaker profit margins and slower growth forecasts in the chemicals sector.
Artículo de análisis • Oct 11

Market Participants Recognise Victrex plc's (LON:VCT) Earnings

When close to half the companies in the United Kingdom have price-to-earnings ratios (or "P/E's") below 16x, you may...
Artículo de análisis • Jun 28

Capital Allocation Trends At Victrex (LON:VCT) Aren't Ideal

When it comes to investing, there are some useful financial metrics that can warn us when a business is potentially in...
Artículo de análisis • May 19

We Think Victrex's (LON:VCT) Healthy Earnings Might Be Conservative

The market seemed underwhelmed by the solid earnings posted by Victrex plc ( LON:VCT ) recently. We have done some...
Artículo de análisis • May 15

Victrex's (LON:VCT) Dividend Will Be £0.1342

Victrex plc's ( LON:VCT ) investors are due to receive a payment of £0.1342 per share on 27th of June. This makes the...
User avatar
Nueva narrativa • May 12

China Plant And Magma Programme Will Expand Market Reach

Initiatives like Project Vista and the new China plant aim to improve sales strategies and expand geographically, enhancing margins and growth potential.
Artículo de análisis • Apr 08

With A 31% Price Drop For Victrex plc (LON:VCT) You'll Still Get What You Pay For

Victrex plc ( LON:VCT ) shareholders that were waiting for something to happen have been dealt a blow with a 31% share...
Artículo de análisis • Mar 24

Victrex (LON:VCT) Is Finding It Tricky To Allocate Its Capital

When researching a stock for investment, what can tell us that the company is in decline? When we see a declining...
Artículo de análisis • Feb 26

Are Investors Undervaluing Victrex plc (LON:VCT) By 49%?

Key Insights Victrex's estimated fair value is UK£18.18 based on 2 Stage Free Cash Flow to Equity Victrex's UK£9.32...
Artículo de análisis • Jan 15

Victrex (LON:VCT) Is Paying Out A Dividend Of £0.4614

Victrex plc ( LON:VCT ) will pay a dividend of £0.4614 on the 21st of February. Based on this payment, the dividend...
Artículo de análisis • Dec 06

Victrex plc (LON:VCT) Stocks Shoot Up 25% But Its P/E Still Looks Reasonable

Victrex plc ( LON:VCT ) shareholders would be excited to see that the share price has had a great month, posting a 25...
Artículo de análisis • Sep 13

Investors Could Be Concerned With Victrex's (LON:VCT) Returns On Capital

If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...
Artículo de análisis • Aug 03

Shareholders Should Be Pleased With Victrex plc's (LON:VCT) Price

With a price-to-earnings (or "P/E") ratio of 29.8x Victrex plc ( LON:VCT ) may be sending very bearish signals at the...
Artículo de análisis • Jul 16

Does Victrex (LON:VCT) Have A Healthy Balance Sheet?

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to...
Artículo de análisis • Jun 14

There Are Reasons To Feel Uneasy About Victrex's (LON:VCT) Returns On Capital

What are the early trends we should look for to identify a stock that could multiply in value over the long term...
Artículo de análisis • May 27

Calculating The Fair Value Of Victrex plc (LON:VCT)

Key Insights Victrex's estimated fair value is UK£14.70 based on 2 Stage Free Cash Flow to Equity With UK£12.96 share...
Artículo de análisis • Mar 16

Does Victrex (LON:VCT) Have A Healthy Balance Sheet?

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
Artículo de análisis • Feb 24

Returns On Capital At Victrex (LON:VCT) Paint A Concerning Picture

When we're researching a company, it's sometimes hard to find the warning signs, but there are some financial metrics...
Artículo de análisis • Jan 12

Victrex plc Just Missed EPS By 5.9%: Here's What Analysts Think Will Happen Next

Shareholders might have noticed that Victrex plc ( LON:VCT ) filed its annual result this time last week. The early...
Artículo de análisis • Dec 08

Victrex (LON:VCT) Will Pay A Dividend Of £0.4614

Victrex plc's ( LON:VCT ) investors are due to receive a payment of £0.4614 per share on 23rd of February. This means...
Artículo de análisis • Nov 23

Investors Could Be Concerned With Victrex's (LON:VCT) Returns On Capital

If you're looking for a multi-bagger, there's a few things to keep an eye out for. Typically, we'll want to notice a...
Artículo de análisis • Oct 19

Is Victrex plc (LON:VCT) Trading At A 22% Discount?

Key Insights Victrex's estimated fair value is UK£17.25 based on 2 Stage Free Cash Flow to Equity Victrex's UK£13.47...

Previsiones de crecimiento de beneficios e ingresos

LSE:VCT - Estimaciones futuras de los analistas y datos financieros pasados (GBP Millions)
FechaIngresosBeneficiosFlujo de caja libreFlujo de caja operativoNúm. de analistas medio
9/30/202833145487511
9/30/202731640446911
9/30/2026303-15436211
3/31/2026294-204969N/A
12/31/202529344970N/A
9/30/2025293284971N/A
6/30/2025295295778N/A
3/31/2025298306585N/A
12/31/2024294235884N/A
9/30/2024291175184N/A
6/30/2024288243267N/A
3/31/2024284311351N/A
12/31/202329646846N/A
9/30/202330762342N/A
6/30/2023325671656N/A
3/31/2023343722970N/A
12/31/2022342743275N/A
9/30/2022341763580N/A
6/30/2022328734290N/A
3/31/20223167049101N/A
12/31/20213117267114N/A
9/30/20213067385127N/A
6/30/20212866473108N/A
3/31/2021265546090N/A
12/31/2020266545279N/A
9/30/2020266544569N/A
6/30/2020283725479N/A
3/31/2020300896389N/A
12/31/201929791N/A85N/A
9/30/201929492N/A80N/A
6/30/201930096N/A85N/A
3/31/201930599N/A91N/A
12/31/2018316105N/A110N/A
9/30/2018326111N/A129N/A
6/30/2018326113N/A127N/A
3/31/2018326115N/A125N/A
12/31/2017308107N/A121N/A
9/30/2017290100N/A118N/A
6/30/201727892N/A114N/A
3/31/201726684N/A111N/A
12/31/201625983N/A97N/A
9/30/201625283N/A83N/A
6/30/201625181N/A78N/A
3/31/201625080N/A72N/A
12/31/201525782N/A80N/A
9/30/201526484N/A88N/A

Previsiones de crecimiento futuro de los analistas

Ingresos vs. Tasa de ahorro: Se prevé que VCT sea rentable en los próximos 3 años, lo que se considera un crecimiento más rápido que la tasa de ahorro (3.6%).

Beneficios vs. Mercado: Se prevé que VCT sea rentable en los próximos 3 años, lo que se considera un crecimiento del mercado superior a la media.

Beneficios de alto crecimiento: Se espera que VCT sea rentable en los próximos 3 años.

Ingresos vs. Mercado: Se prevé que los ingresos (4% al año) de VCT crezcan más rápidamente que los del mercado UK (3.7% al año).

Ingresos de alto crecimiento: Se prevé que los ingresos 4% al año) de VCT crezcan más despacio que 20% al año.


Previsiones de crecimiento de los beneficios por acción


Rentabilidad financiera futura

ROE futura: Se prevé que la rentabilidad financiera de VCT sea baja dentro de 3 años (14.7%).


Descubre empresas en crecimiento

7D

1Y

7D

1Y

7D

1Y

Análisis de la empresa y estado de los datos financieros

DatosÚltima actualización (huso horario UTC)
Análisis de la empresa2026/09/18 21:09
Precio de las acciones al final del día2026/09/18 00:00
Beneficios2026/03/31
Ingresos anuales2025/09/30

Fuentes de datos

Los datos utilizados en nuestro análisis de empresas proceden de S&P Global Market Intelligence LLC. Los siguientes datos se utilizan en nuestro modelo de análisis para generar este informe. Los datos están normalizados, lo que puede introducir un retraso desde que la fuente está disponible.

PaqueteDatosMarco temporalEjemplo Fuente EE.UU. *
Finanzas de la empresa10 años
  • Cuenta de resultados
  • Estado de tesorería
  • Balance
  • Formulario SEC 10-K
  • Formulario SEC 10-Q
Estimaciones del consenso de analistas+3 años
  • Previsiones financieras
  • Objetivos de precios de los analistas
  • Informes de análisis
  • Blue Matrix
Precios de mercado30 años
  • Precios de las acciones
  • Dividendos, escisiones y acciones
  • Datos de mercado ICE
  • Formulario S-1 de la SEC
Propiedad10 años
  • Accionistas principales
  • Información privilegiada
  • Formulario SEC 4
  • Formulario SEC 13D
Gestión10 años
  • Equipo directivo
  • Consejo de Administración
  • Formulario SEC 10-K
  • Formulario SEC DEF 14A
Principales avances10 años
  • Anuncios de empresas
  • Formulario SEC 8-K

* Ejemplo para valores de EE.UU., para no EE.UU. se utilizan formularios y fuentes normativas equivalentes.

A menos que se especifique lo contrario, todos los datos financieros se basan en un periodo anual, pero se actualizan trimestralmente. Esto se conoce como datos de los últimos doce meses (TTM) o de los últimos doce meses (LTM). Más información.

Modelo de análisis y copo de nieve

Los detalles del modelo de análisis utilizado para generar este informe están disponibles en nuestra página de Github, también tenemos guías sobre cómo utilizar nuestros informes y tutoriales en Youtube.

Conozca al que diseñó y construyó el modelo de análisis Simply Wall St.

Métricas industriales y sectoriales

Simply Wall St calcula cada 6 horas nuestras métricas sectoriales y de sección. Los detalles de nuestro proceso están disponibles en Github.

Fuentes analistas

Victrex plc está cubierta por 28 analistas. 11 de esos analistas presentaron las estimaciones de ingresos o ganancias utilizadas como datos para nuestro informe. Las estimaciones de los analistas se actualizan a lo largo del día.

AnalistaInstitución
James StewartBarclays
Katie RichardsBarclays
Gunther ZechmannBarclays

Toma mejores decisiones de inversión en cualquier lugar

Escanea para descargar
Abrir AppStoreAbrir Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
Ver fuentes de datos
Mercados
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Ideas de inversión
  • Empresas infravaloradas
  • Potentes generadores de dividendos
  • Compras con información privilegiada
  • Energía nuclear
  • Vehículos autónomos
  • Inteligencia artificial
  • Criptomonedas y blockchain
  • Ciberseguridad
  • Más ideas
Comunidades de acciones
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Herramientas y funciones
  • Seguimiento de la cartera
  • Buscador de valores y alertas
  • Narrativas y Valores de Feria
  • Calculadora de dividendos
Noticias y descubrimientos
  • Últimas noticias de stock
  • Incidencias del mercado global
  • El Foxhole
  • Ideas de inversión
  • Narrativas de la comunidad
  • Qué hay de nuevo
Simply Wall St
  • Planes y precios
  • Publicidad
  • Quiénes somos
  • Contacte con nosotros
  • Empleos
  • Centro de ayuda
  • Aprender a invertir en bolsa
  • Programa de afiliados
  • Empresas y negocios
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Términos y condiciones de uso
  • Política de privacidad
  • Términos de IA
  • Guía de servicios financieros